Fair Value Measurement Roll Forward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent Earn-out Liability	$ 5,491	$ 25,572	$ 2,589	$ 26,300
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances		55,158	2,589
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	(16,247)	(32,091)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3	(3,379)
Fair value measurements with unobservable inputs reconciliation, other	(496)
Currency translation on earn-out	$ 41	(84)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Change in fair value of contingent earn-out
Pursuit Vascular, Inc. [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent Earn-out Liability	$ 26,300				$ 26,300
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3			$ (26,300)
Smiths Medical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent earn-out liability, Noncurrent		53,500
Foreign Infusion System Supplier
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent earn-out liability, Noncurrent		$ 1,600